The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Freiman Paul E since 2006.
The trader's CIK number is 1184160.
At the time of the last reporting, Freiman Paul E was the Other of Penwest Pharmaceuticals Co. (stock ticker symbol PPCO).
Also see all insider trading activities at Penwest Pharmaceuticals Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | NTII | 0 | $0 | 2,466 | $1,277 | 0 | $0 |
| 2007 | NTII | 3,000 | $9,900 | 100,000 | $265,181 | 145,000 | $258,179 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | PPCO | 0 | $0 | 3,466 | $8,145 | 0 | $0 |
| 2008 | PPCO | 0 | $0 | 9,000 | $25,965 | 0 | $0 |
| 2007 | PPCO | 0 | $0 | 0 | $0 | 6,488 | $42,484 |
| 2006 | PPCO | 0 | $0 | 10,000 | $199,000 | 0 | $0 |
1. Neurobiological Technologies Inc /ca/ (NTII)
2. Penwest Pharmaceuticals Co (PPCO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-12-10 | NTII | Sale | 1,000 | .61 | 610 |
| 2008-12-16 | NTII | Sale | 1,000 | .57 | 570 |
| 2008-12-17 | NTII | Sale | 466 | .21 | 97 |
| 2007-12-03 | NTII | Buy | 3,000 | 3.30 | 9,900 |
| 2007-02-21 | NTII | Sale | 35,437 | 2.73 | 96,672 |
| 2007-02-22 | NTII | Sale | 64,563 | 2.61 | 168,509 |
| 2007-02-21 | NTII | Option Ex | 35,437 | 1.88 | 66,444 |
| 2007-02-22 | NTII | Option Ex | 109,563 | 1.75 | 191,735 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-09-03 | PPCO | Sale | 3,466 | 2.35 | 8,145 |
| 2008-06-10 | PPCO | Sale | 5,000 | 3.08 | 15,425 |
| 2008-05-12 | PPCO | Sale | 4,000 | 2.63 | 10,540 |
| 2007-08-07 | PPCO | Option Ex | 4,489 | 6.12 | 27,472 |
| 2007-05-29 | PPCO | Option Ex | 1,999 | 7.51 | 15,012 |
| 2006-05-01 | PPCO | Sale | 10,000 | 19.90 | 199,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Freiman Paul E (Other of Penwest Pharmaceuticals Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.